On July 7, BeOne Medicines (06160.HK) fell 3.1% in regular trading, trading at HK$184.3 per share, with turnover of HK$630 million.
Within the Biotechnology sector where BeOne Medicines belongs, the overall sector is under broad pressure. Among individual stocks, AKESO down 4.61%, INNOVENT BIO down 3.65%, SKB BIO down 2.29%, 3SBIO down 5.45%, REMEGEN down 6.43%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)